Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: John Starks who wrote (487)	3/8/1999 1:50:00 PM
From: scaram(o)uche	Respond to of 4974

Really appreciate your commentary and research. (eom)

To: John Starks who wrote (487)	3/8/1999 1:55:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4974

Any guesses as to why Hyseq is getting beat up lately? So glad I did not hold on to that one... somebody surely does not want their shares and does not seem to care where they get out, another batch was just dumped a bit ago at 3 1/8--and as usual the spread is wide. The CNBC thing about snip maps just now was kind of a quickie, but the fellow from the WSJ threw out a bunch of big cap pharma names again--Glaxo again seemed to get the best press on this. But he did get five seconds to adress the biotech stocks--and threw out GENXY, MLNM, INCY, and CRGN real quick, probably too fast for anybody watching to scrawl any notes down--it was just like Rick previewed over on the VD's portfolio thread. Harmon is so damn quick, how does he catch all this stuff? So, let's try for a second to get back on topic-- which of the genomics companies are in the BVF? Any of the SNP-oriented companies?